Americafirst Capital Management LLC Trims Stake in Aetna Inc (AET)
Americafirst Capital Management LLC trimmed its holdings in Aetna Inc (NYSE:AET) by 48.7% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 8,590 shares of the company’s stock after selling 8,143 shares during the quarter. Aetna accounts for 1.6% of Americafirst Capital Management LLC’s portfolio, making the stock its 12th largest holding. Americafirst Capital Management LLC’s holdings in Aetna were worth $1,304,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also bought and sold shares of AET. BlackRock Inc. raised its stake in shares of Aetna by 3,374.9% in the first quarter. BlackRock Inc. now owns 30,712,219 shares of the company’s stock valued at $3,917,344,000 after purchasing an additional 29,828,390 shares in the last quarter. FMR LLC raised its stake in Aetna by 73.8% during the second quarter. FMR LLC now owns 13,736,800 shares of the company’s stock worth $2,085,659,000 after acquiring an additional 5,833,567 shares in the last quarter. Janus Henderson Group PLC raised its stake in Aetna by 9,446.2% during the second quarter. Janus Henderson Group PLC now owns 4,328,900 shares of the company’s stock worth $657,255,000 after acquiring an additional 4,283,553 shares in the last quarter. Capital World Investors raised its stake in Aetna by 8.9% during the second quarter. Capital World Investors now owns 20,769,004 shares of the company’s stock worth $3,153,358,000 after acquiring an additional 1,688,767 shares in the last quarter. Finally, Vanguard Group Inc. raised its stake in Aetna by 3.8% during the first quarter. Vanguard Group Inc. now owns 23,117,526 shares of the company’s stock worth $2,948,640,000 after acquiring an additional 838,578 shares in the last quarter. 89.52% of the stock is owned by institutional investors.
Aetna Inc (AET) traded down 1.86% on Friday, hitting $151.61. The company’s stock had a trading volume of 551,884 shares. Aetna Inc has a 12 month low of $104.59 and a 12 month high of $164.52. The stock has a market cap of $50.35 billion, a PE ratio of 33.65 and a beta of 0.53. The firm has a 50 day moving average of $158.32 and a 200-day moving average of $148.67.
Aetna (NYSE:AET) last issued its quarterly earnings results on Thursday, August 3rd. The company reported $3.42 EPS for the quarter, beating the Zacks’ consensus estimate of $2.34 by $1.08. The company had revenue of $15.52 billion during the quarter, compared to the consensus estimate of $15.34 billion. Aetna had a return on equity of 32.53% and a net margin of 7.62%. Aetna’s revenue was down 2.7% on a year-over-year basis. During the same period last year, the business posted $2.21 earnings per share. On average, analysts expect that Aetna Inc will post $9.55 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Thursday, October 12th will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.29%. The ex-dividend date is Wednesday, October 11th. Aetna’s payout ratio is 43.67%.
Several research analysts have issued reports on the company. Zacks Investment Research upgraded Aetna from a “hold” rating to a “buy” rating and set a $174.00 price objective for the company in a research note on Thursday. Argus reiterated a “buy” rating and set a $185.00 price objective (up from $165.00) on shares of Aetna in a research note on Tuesday, September 12th. BidaskClub lowered Aetna from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 19th. Deutsche Bank AG increased their price objective on Aetna from $144.00 to $157.00 and gave the stock a “hold” rating in a research note on Thursday, July 13th. Finally, Morgan Stanley increased their target price on Aetna from $172.00 to $179.00 and gave the stock an “overweight” rating in a report on Thursday, August 17th. Seven investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $160.99.
TRADEMARK VIOLATION WARNING: This story was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another publication, it was copied illegally and reposted in violation of US and international copyright legislation. The legal version of this story can be read at https://www.thecerbatgem.com/2017/10/13/americafirst-capital-management-llc-trims-stake-in-aetna-inc-aet.html.
In other Aetna news, President Karen S. Lynch sold 15,271 shares of the stock in a transaction on Monday, September 18th. The stock was sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the completion of the transaction, the president now directly owns 64,261 shares of the company’s stock, valued at $10,404,498.51. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Margaret M. Mccarthy sold 10,288 shares of the stock in a transaction on Friday, September 15th. The shares were sold at an average price of $162.85, for a total value of $1,675,400.80. Following the transaction, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at $5,465,734.55. The disclosure for this sale can be found here. Company insiders own 0.90% of the company’s stock.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).
Receive News & Stock Ratings for Aetna Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc and related stocks with our FREE daily email newsletter.